Interestingly first in vitro investigations also show efficiency of antibody-mediated inhibition of CEACAM5/CEACAM1 interaction to reduce CEACAM1-dependent NK cell inhibition in pancreatic and CRC cells (113). The gene discussed is CEACAM1; the disease is colorectal carcinoma.